DJIA 17,265.99 109.14 0.64%
NASDAQ 4,593.43 31.24 0.68%
S&P 500 2,011.36 9.79 0.49%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

60.31 0.43 (0.72%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $60.31 0.72%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $60.13
Previous Close $59.88
Daily Range $59.82 - $60.34
52-Week Range $44.62 - $61.33
Market Cap $174.0B
P/E Ratio 31.52
Dividend (Yield) $1.76 (2.9%)
Ex-Dividend Date
Dividend Pay Date
09/11/14
10/07/14
Volume 7,990,460
Average Daily Volume 7,971,222
Current FY EPS $3.49

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

The Surprising 7 States Where Melanoma Most Often Occurs

Of the seven most common types of cancer, melanoma incidence was the only one to rise between 2000 and 2009. Find out in which seven states melanoma occurs most often, as well as what's being done to curb this terrible form of skin cancer.

Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog

Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog

Roadmap Capital's Hugh Cleland And Stephen Ireland: Due Diligence Rules In Biotech Investment

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog

Dow Movers: MRK, DD

Dow Jones (DJIA) Today: E I Du Pont De Nemours & Company (DD) Leads The Day Higher, Merck (MRK) Lags

Merck Presents First Phase 3 Data In Japanese Patients for Omarigliptin, An Investigational Once-Wee

Merck Presents First Phase 3 Data In Japanese Patients for Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes

The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

3 Stocks Reiterated As A Buy: MRK, KO, MET

The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

See More MRK News...

MRK's Top Competitors

MRK $60.31 (0.72%)
Current stock: MRK
JNJ $107.35 (1.09%)
Current stock: JNJ
NVS $94.80 (0.08%)
Current stock: NVS
RHHBY $37.90 (1.43%)
Current stock: RHHBY